28. April 2020 | Corporate News

Marinomed receives FFG funding to research SARS-CoV-2 therapy based on Carragelose®

Press release

The full press release is available as download here:

Marinomed receives FFG funding to research SARS-CoV-2 therapy based on Carragelose®
(129 KB)